NDLI: Structure-Transport Relationship for the Intestinal Small-Peptide Carrier: Is the Carbonyl Group of the Peptide Bond Relevant for Transport?

Content Provider	Springer Nature Link
Author	Schoenmakers, Ronald G. Stehouwer, Marco C. Tukker, Josef J.
Copyright Year	1999
Abstract	Purpose. The objective of this study was to determine the influence of the peptide bond with emphasis on the carbonyl group on the interaction with and transport by the intestinal small-peptide carrier. Therefore enalapril, a known substrate for the small-peptide carrier, has been modified to an analogue with a reduced peptide bond, enamipril. The transport characteristics of both compounds have been determined. Methods. The in vitro transport studies were performed using rat ileum in Ussing chambers. The transport of enalapril and enamipril were measured in a concentration range from 0.5-8 mM in both directions across the ileum, in the presence and absence of inhibitors. The interaction with the small-peptide carrier was studied by evaluating the ability of enalapril and its analogue enamipril to inhibit the transport rate of amoxycillin. Results. Enalapril shows, besides passive diffusion (P$_{m}$ 3.06 ± 0.14 · 10$^{-6}$ cm/s), saturable transport kinetics (J$_{max}$ = 16 ± 5 nmol/ h·cm$^{2}$, K$_{m}$ = 1.86 ± 0.64 mM) which can be inhibited with 10 mM cephalexin. The analogue with a reduced peptide bond does not show saturable transport from the mucosal to the serosal side, and cephalexin does not inhibit the flux of enamipril. However, the transport of enamipril from the serosal to mucosal side of the intestinal membrane is saturable and can be inhibited by 100 μM verapamil. Although enamipril is not a substrate for the small-peptide carrier in contrast to enalapril, both enalapril and enamipril are able to inhibit the active transport of amoxycillin with a K$_{i}$ of 0.41± 0.24 mM and 0.24 ± 0.12 mM respectively. Conclusions. The reduction of the peptide bond of enalapril results in a compound, enamipril, which does not show polarized and saturable transport from the mucosal to the serosal side of the intestinal tissue. Also because the transport of enamipril cannot be inhibited by cephalexin, the analogue with the reduced peptide bond is no longer a substrate for the intestinal small-peptide carrier. Therefore, it can be concluded that the carbonyl group is an essential structural requirement for transport by the small-peptide carrier. In contrast, the interaction with the small-peptide carrier is still present, shown by the inhibition of the fluxes of amoxycillin. Reduction of the peptide bond of enalapril resulted in a new substrate for the P-glycoprotein efflux pump.
Starting Page	62
Ending Page	68
Page Count	7
File Format	PDF
ISSN	07248741
Journal	Pharmaceutical Research
Volume Number	16
Issue Number	1
e-ISSN	1573904X
Language	English
Publisher	Kluwer Academic Publishers-Plenum Publishers
Publisher Date	1999-01-01
Publisher Place	New York
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Pharmacology/Toxicology Pharmacy Biochemistry Medical Law Biomedical Engineering
Content Type	Text
Resource Type	Article
Subject	Organic Chemistry Pharmacology Molecular Medicine Pharmacology (medical) Biotechnology Pharmaceutical Science

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Intestinal Peptide Transport Systems and Oral Drug Availability

Application of Fractal Kinetics for Carrier-Mediated Transport of Drugs Across Intestinal Epithelial Membrane

Cellular Delivery of Oligonucleotides by Synthetic Import Peptide Carrier

Heterogeneous Tube Model for the Study of Small Intestinal Transit Flow

Intestinal Transport of Gentamicin with a Novel, Glycosteroid Drug Transport Agent

Structure-Skin Permeability Relationship of Dendrimers

Effects of Peptide Structure on Transport Properties of Seven Thyrotropin Releasing Hormone (TRH) Analogues in a Human Intestinal Cell Line (Caco-2)

Intestinal Absorption of Miltefosine: Contribution of Passive Paracellular Transport

In vivo and In vitro Evaluations of Intestinal Gabapentin Absorption: Effect of Dose and Inhibitors on Carrier-Mediated Transport

Structure-Transport Relationship for the Intestinal Small-Peptide Carrier: Is the Carbonyl Group of the Peptide Bond Relevant for Transport?

Similar Documents

Intestinal Peptide Transport Systems and Oral Drug Availability

Application of Fractal Kinetics for Carrier-Mediated Transport of Drugs Across Intestinal Epithelial Membrane

Cellular Delivery of Oligonucleotides by Synthetic Import Peptide Carrier

Heterogeneous Tube Model for the Study of Small Intestinal Transit Flow

Intestinal Transport of Gentamicin with a Novel, Glycosteroid Drug Transport Agent

Structure-Skin Permeability Relationship of Dendrimers

Effects of Peptide Structure on Transport Properties of Seven Thyrotropin Releasing Hormone (TRH) Analogues in a Human Intestinal Cell Line (Caco-2)

Intestinal Absorption of Miltefosine: Contribution of Passive Paracellular Transport

In vivo and In vitro Evaluations of Intestinal Gabapentin Absorption: Effect of Dose and Inhibitors on Carrier-Mediated Transport

Structure-Transport Relationship for the Intestinal Small-Peptide Carrier: Is the Carbonyl Group of the Peptide Bond Relevant for Transport?